Northwest Bancshares’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.18M | Sell |
5,425
-30
| -0.5% | -$6.66K | 0.23% | 75 |
|
|
2025
Q4 | $1.25M | Sell |
5,455
-433
| -7% | -$98.6K | 0.24% | 74 |
|
|
2025
Q3 | $1.36M | Hold |
5,888
| – | – | 0.23% | 74 |
|
|
2025
Q2 | $1.09M | Sell |
5,888
-55
| -0.9% | -$10.2K | 0.19% | 83 |
|
|
2025
Q1 | $1.25M | Hold |
5,943
| – | – | 0.23% | 73 |
|
|
2024
Q4 | $1.06M | Sell |
5,943
-133
| -2% | -$24.5K | 0.2% | 82 |
|
|
2024
Q3 | $1.2M | Sell |
6,076
-81
| -1% | -$15.1K | 0.2% | 79 |
|
|
2024
Q2 | $1.06M | Sell |
6,157
-400
| -6% | -$66.3K | 0.18% | 76 |
|
|
2024
Q1 | $1.19M | Sell |
6,557
-60
| -0.9% | -$10.3K | 0.19% | 78 |
|
|
2023
Q4 | $1.03M | Sell |
6,617
-84
| -1% | -$12.2K | 0.19% | 74 |
|
|
2023
Q3 | $999K | Buy |
6,701
+376
| +6% | +$55.2K | 0.19% | 78 |
|
|
2023
Q2 | $852K | Sell |
6,325
-20,444
| -76% | -$3M | 0.15% | 87 |
|
|
2023
Q1 | $4.27M | Sell |
26,769
-27,482
| -51% | -$4.2M | 0.82% | 43 |
|
|
2022
Q4 | $8.77M | Sell |
54,251
-2,352
| -4% | -$361K | 1.76% | 6 |
|
|
2022
Q3 | $7.6M | Sell |
56,603
-80
| -0.1% | -$11.5K | 1.77% | 6 |
|
|
2022
Q2 | $8.68M | Sell |
56,683
-1,189
| -2% | -$182K | 1.96% | 6 |
|
|
2022
Q1 | $9.38M | Sell |
57,872
-2,034
| -3% | -$295K | 1.8% | 6 |
|
|
2021
Q4 | $8.11M | Buy |
59,906
+387
| +0.7% | +$45.7K | 1.59% | 9 |
|
|
2021
Q3 | $6.42M | Sell |
59,519
-858
| -1% | -$98K | 1.46% | 9 |
|
|
2021
Q2 | $6.8M | Sell |
60,377
-1,737
| -3% | -$196K | 1.54% | 9 |
|
|
2021
Q1 | $6.72M | Buy |
62,114
+1,384
| +2% | +$148K | 1.59% | 8 |
|
|
2020
Q4 | $6.51M | Buy |
60,730
+1,864
| +3% | +$179K | 1.67% | 5 |
|
|
2020
Q3 | $5.16M | Sell |
58,866
-3,270
| -5% | -$308K | 1.33% | 13 |
|
|
2020
Q2 | $6.1M | Buy |
62,136
+11,003
| +22% | +$969K | 1.66% | 7 |
|
|
2020
Q1 | $3.9M | Buy |
51,133
+494
| +1% | +$42.1K | 1.94% | 12 |
|
|
2019
Q4 | $4.48M | Sell |
50,639
-2,517
| -5% | -$209K | 1.73% | 11 |
|
|
2019
Q3 | $4.03M | Buy |
53,156
+6,788
| +15% | +$465K | 1.66% | 9 |
|
|
2019
Q2 | $3.37M | Buy |
46,368
+3,548
| +8% | +$279K | 1.42% | 17 |
|
|
2019
Q1 | $3.45M | Buy |
42,820
+3,696
| +9% | +$302K | 1.49% | 11 |
|
|
2018
Q4 | $3.61M | Buy |
39,124
+8,187
| +26% | +$720K | 1.74% | 6 |
|
|
2018
Q3 | $2.93M | Buy |
30,937
+8,898
| +40% | +$844K | 1.3% | 13 |
|
|
2018
Q2 | $2.04M | Buy |
22,039
+6,735
| +44% | +$658K | 0.86% | 25 |
|
|
2018
Q1 | $1.45M | Sell |
15,304
-40
| -0.3% | -$4.39K | 0.6% | 46 |
|
|
2017
Q4 | $1.48M | Buy |
+15,344
| New | +$1.45M | 0.61% | 46 |
|
Other funds holding ABBV
VCM
VPM
Northwest Bancshares's ABBV Position: Q1 2026 in Review
Northwest Bancshares reduced its AbbVie (ABBV) stake by 0.55% in Q1 2026, selling an estimated $6.66K and leaving 5,425 shares worth $1.18M. The position accounts for 0.23% of the portfolio, ranked #75.
Northwest Bancshares first reported a position in ABBV in Q4 2017 and has held it in 34 quarters since. The position peaked at $9.38M in Q1 2022. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Northwest Bancshares held 5,425 shares of AbbVie worth $1.18M as of Q1 2026.
- Northwest Bancshares sold 30 AbbVie shares in Q1 2026, an estimated $6.66K.
- AbbVie made up 0.23% of Northwest Bancshares's portfolio in Q1 2026, its #75 holding.
- Northwest Bancshares first reported a position in AbbVie in Q4 2017 and has held it in 34 quarters since.
- Northwest Bancshares's AbbVie position peaked at $9.38M in Q1 2022.
- 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Northwest Bancshares's 13F filing for Q1 2026, filed 12 May 2026.